- Nachrichtendetail
-
28.03.2024 12:06:41 - dpa-AFX: *GILEAD SCIENCES, XILIO THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP TUMOR-ACTIVATED IL-12 PROGRAM, XTX301
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GILEAD SCIENCES DL-,001 | 885823 | Frankfurt | 65,500 | 25.06.24 13:23:22 | -0,750 | -1,13% | 0,000 | 0,000 | 65,850 | 66,250 |
